[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100640892":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":27,"locations":33,"responsibleParty":48,"collaborators":23,"id":52,"slug":23,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":23,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":23,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":23,"overallStatus":35,"whyStopped":23,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group SA- QLB","EXPERIMENTAL","Patients will receive a supra-iliac anterior quadratus lumborum block (SA-QLB) using 20mL of bupivacaine 0.25%.",[13],"Other: Supra-iliac anterior quadratus lumborum block",{"label":15,"type":10,"description":16,"interventionNames":17},"Group PENG","Patients will receive an ultrasound-guided pericapsular nerve group (PENG) block using 20mL of bupivacaine 0.25%.",[18],"Other: Pericapsular nerve group block",[20,24],{"type":6,"name":21,"description":11,"armGroupLabels":22,"otherNames":23},"Supra-iliac anterior quadratus lumborum block",[9],null,{"type":6,"name":25,"description":16,"armGroupLabels":26,"otherNames":23},"Pericapsular nerve group block",[15],[28],{"name":29,"role":30,"phone":31,"phoneExt":23,"email":32},"Mohammed S Elsharkawy, MD","CONTACT","00201148207870","mselsharkawy@med.tanta.edu.eg",[34],{"facility":5,"status":35,"city":36,"state":37,"zip":38,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"RECRUITING","Tanta","El-Gharbia","31527","Egypt",{"type":41,"coordinates":42},"Point",[43,44],31.00192,30.78847,{"lat":44,"lon":43},[47],{"name":29,"role":30,"phone":31,"phoneExt":23,"email":32},{"type":49,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"PRINCIPAL_INVESTIGATOR","Mohammed Said ElSharkawy","Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.","100640892",false,"NCT07606794","Supra-Iliac Anterior Quadratus Lumborum Block and Pericapsular Nerve Group (PENG) Block for Analgesia After Total Hip Arthroplasty","A Randomized Clinical Non-Inferiority Trial Comparing Supra-Iliac Anterior Quadratus Lumborum Block and Pericapsular Nerve Group (PENG) Block for Analgesia After Total Hip Arthroplasty","Inclusion Criteria:\n\n* Age from 18 to 75 years.\n* Both sexes.\n* American Society of Anesthesiologists (ASA) classification I-III.\n* Scheduled for primary elective unilateral total hip arthroplasty (THA) under spinal anesthesia.\n\nExclusion Criteria:\n\n* Known allergies to the drugs used.\n* Infection at the injection site.\n* Bleeding disorders.\n* Recognized neuromuscular disorders.\n* Opioid addiction or dependence.\n* Contraindications to regional anesthesia or peripheral nerve blockade.\n* Body mass index (BMI) \\> 40 kg\u002Fm².\n* Associated decompensated cardiac, hepatic, respiratory, or renal diseases.","ALL","18 Years","75 Years",{"count":62,"type":63},50,"ESTIMATED","INTERVENTIONAL",[66],"NA","This study aims to compare the analgesic efficacy of supra-iliac anterior quadratus lumborum block (SA-QLB) and pericapsular nerve group (PENG) block in patients undergoing total hip arthroplasty (THA).",[69,70,71,72],"Supra-Iliac Anterior Quadratus Lumborum Block","Pericapsular Nerve Group Block","Analgesia","Total Hip Arthroplasty","2026-06-22",{"date":75,"type":76},"2026-06-23","ACTUAL",{"date":78,"type":76},"2026-05-23",{"date":80,"type":63},"2026-10-30",{"name":5,"class":6},1]